Home > Insider Trading > Filing (0001104659-25-055325)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1845459	Nkgen Biotech Inc.	NKGN	()	4

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1235503	Peggy Cherng	1120 N. Town Center Drive, Suite 150 Las Vegas NV 89144	No	No	Yes	No
2034776	Cfic-2015 Nv Family Investments, Llc	1120 N. Town Center Drive, Suite 150 Las Vegas NV 89144	No	No	Yes	No
2035448	Jin-Chan Andrew Cherng	1120 N. Town Center Drive, Suite 150 Las Vegas NV 89144	No	No	Yes	No

Transaction Summary

Purchased:	19,669,552 shares	Avg. Price: $0.13	Total Value: $2,500,000.06
Number of Shares After Transactions:	21,752,885 shares

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2025-05-27	19,669,552	$0.13	21,752,885	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Warrant	Acquisiton	2025-05-27	39,339,103	$0.13	39,339,103	$0.13

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
39,339,103	2025-05-27	2030-05-27	No	4	P	Direct

Footnotes

On May 27, 2025, CFIC-2015 NV Family Investments, LLC ("CFIC-2015") completed the purchase of an aggregate of 19,669,552 shares of the Issuer's common stock, par value $0.0001 per share ("Common Stock") at a purchase price of $0.1271 per share (the "Share Price"), subject to adjustment, for an aggregate purchase price of $2,500,000.00 pursuant to a Stock Purchase Agreement dated May 14, 2025 between the CFIC-2015 and the Issuer. Andrew Cherng and Peggy Cherng together own 100% of the voting interests of CFIC-2015.
On May 27, 2025, the Issuer issued a common stock purchase warrant to CFIC-2015 for the purchase of up to 39,339,103 shares of Common Stock, exercisable at the Share Price (the "2025 Warrant").